AllianceBernstein’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-71,500
| Closed | -$346K | – | 3316 |
|
|
2020
Q1 | $346K | Sell |
71,500
-1,812,018
| -96% | -$11.7M | ﹤0.01% | 2542 |
|
|
2019
Q4 | $20M | Buy |
1,883,518
+274,433
| +17% | +$2.72M | 0.01% | 821 |
|
|
2019
Q3 | $16.8M | Buy |
1,609,085
+1,565,285
| +3,574% | +$20.5M | 0.01% | 864 |
|
|
2019
Q2 | $671K | Hold |
43,800
| – | – | ﹤0.01% | 2481 |
|
|
2019
Q1 | $563K | Buy |
43,800
+7,300
| +20% | +$82.5K | ﹤0.01% | 2478 |
|
|
2018
Q4 | $347K | Buy |
36,500
+6,500
| +22% | +$84.3K | ﹤0.01% | 2649 |
|
|
2018
Q3 | $498K | Buy |
30,000
+1,500
| +5% | +$24.1K | ﹤0.01% | 2620 |
|
|
2018
Q2 | $457K | Buy |
28,500
+5,000
| +21% | +$89.3K | ﹤0.01% | 2647 |
|
|
2018
Q1 | $360K | Buy |
23,500
+4,200
| +22% | +$65.5K | ﹤0.01% | 2632 |
|
|
2017
Q4 | $301K | Hold |
19,300
| – | – | ﹤0.01% | 2709 |
|
|
2017
Q3 | $214K | Hold |
19,300
| – | – | ﹤0.01% | 2905 |
|
|
2017
Q2 | $178K | Buy |
+19,300
| New | +$161K | ﹤0.01% | 3017 |
|
|
2015
Q2 | – | Sell |
-1,300
| Closed | -$19K | – | 3371 |
|
|
2015
Q1 | $19K | Hold |
1,300
| – | – | ﹤0.01% | 3275 |
|
|
2014
Q4 | $22K | Hold |
1,300
| – | – | ﹤0.01% | 3221 |
|
|
2014
Q3 | $16K | Sell |
1,300
-1,300
| -50% | -$16K | ﹤0.01% | 3234 |
|
|
2014
Q2 | $38K | Buy |
2,600
+2,360
| +983% | +$36.2K | ﹤0.01% | 3149 |
|
|
2014
Q1 | $5K | Buy |
240
+221
| +1,163% | +$5.36K | ﹤0.01% | 3341 |
|
|
2013
Q4 | $0 | Sell |
19
-4,800
| -100% | -$128K | ﹤0.01% | 3497 |
|
|
2013
Q3 | $218K | Sell |
4,819
-1,132
| -19% | -$36.9K | ﹤0.01% | 2829 |
|
|
2013
Q2 | $142K | Buy |
+5,951
| New | +$94.8K | ﹤0.01% | 2907 |
|
AllianceBernstein's STML Position: Q2 2020 in Review
AllianceBernstein sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 71,500 shares — an estimated $346K sold.
AllianceBernstein first reported a position in STML in Q2 2013 and held it in 20 quarters. The position peaked at $20M in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- AllianceBernstein reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- AllianceBernstein sold 71,500 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $346K.
- AllianceBernstein first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 20 quarters.
- AllianceBernstein's Stemline Therapeutics, Inc. position peaked at $20M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.